Of the 287 patients with LV metastatic disease on the trial who were treated with ADT + AR blocker on either arm, had DNA available, and did not receive concurrent docetaxel, 147 inherited the adrenal-permissive genotype, and 140 inherited the adrenal-restrictive genotype. Here, AR is linked to metastatic neoplasm.